Election 2014
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 21, 10:16
2570.00
14 (0.55%)
VOLUME 3,434
LIVE
NSE
Apr 21, 10:16
2568.60
16.4 (0.64%)
VOLUME 37,971
Announcements on Dr Reddys Labs

18th-Apr-2014 11:08Source: BSE

Dr Reddys Labs- Shareholding Pattern For March 31, 2014

Dr Reddys Laboratories Ltd has informed BSE about the Shareholding Pattern as on March 31, 2014.

16th-Apr-2014 10:41Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release April 16, 2014, titled, "Dr. Reddy''s announces the Launch of Eszopiclone Tablets C-IV."

16th-Apr-2014 10:18Source: BSE

Dr Reddys Labs- Dr. Reddy's announces the Launch of Eszopiclone Tablets C-IV

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated April 16, 2014 titled "Dr. Reddy''s announces the Launch of Eszopiclone Tablets C-IV". Dr Reddys Laboratories has launch...

11th-Apr-2014 20:22Source: BSE

Dr Reddys Labs- FY14 results on May 13, 2014

Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2014, inter alia, to consider and approve the Audited Financial Results of t...

9th-Apr-2014 09:54Source: BSE

Dr Reddys Labs- Publish Audited Results

Dr Reddys Laboratories Ltd has informed BSE that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2014 instead of unaudited/audite...

28th-Mar-2014 15:58Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

27th-Mar-2014 10:53Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2014, titled "Dr. Reddy''s announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Ta...

27th-Mar-2014 10:22Source: BSE

Dr Reddys Labs- Dr Reddys announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets

Dr Reddys Laboratories Ltd has submitted to BSE a copy of Press Release dated March 27, 2014 titled "Dr Reddys announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets." Dr Redd...

20th-Mar-2014 15:28Source: NSE

Dr. Reddy's Laboratories Limited

The Exchange had sought clarification from Dr. Reddy''s Laboratories Limited with respect to a news item captioned "Lawsuit filed against DRL in US". The Company has clarified that "Dr. Reddy''s Labor...

12th-Mar-2014 11:32Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

1 2 3 4 5 Next >>
Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2014-05-13

Audited Results & Dividend

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.